Because water handling is central to decompensation, copeptin, a stable vasopressin surrogate, represents a liver-disease–specific biomarker that correlates with circulatory dysfunction and prognosis in cirrhosis and could be explored to anticipate water-balance responses to SGLT2 inhibition [178]. This evidence concerns the gene SLC5A2 and Cirrhosis.